IRON
Disc Medicine, Inc.Healthcare · $2.5B market cap
Verdict
We can't put a fair value on IRON right now. It has lost money in each of its last 3 years, and our valuation needs recent profits to project from.
Business quality
0 of 5 clear the 10% bar. What are the Big Five?
Follow IRON
Track it on your watchlist and see the full analysis. Free.
Create a free accountInsider activity
Since Sep 1, 2026: no open-market purchases and 15 sales worth $4.5M. Why purchases matter
Sales
Bitterman Kevin
director · 2026-09-04
Sold
$1K
Bitterman Kevin
director · 2026-09-04
Sold
$61K
Bitterman Kevin
director · 2026-09-04
Sold
$73K
Bitterman Kevin
director · 2026-09-03
Sold
$4K
Bitterman Kevin
director · 2026-09-03
Sold
$187K
Show all 15 salesShow fewer
Bitterman Kevin
director · 2026-09-03
Sold
$225K
Bitterman Kevin
director · 2026-09-02
Sold
$162
Bitterman Kevin
director · 2026-09-02
Sold
$729
Bitterman Kevin
director · 2026-09-02
Sold
$810
Bitterman Kevin
director · 2026-09-02
Sold
$41K
Bitterman Kevin
director · 2026-09-02
Sold
$1.8M
Bitterman Kevin
director · 2026-09-02
Sold
$2.1M
Bitterman Kevin
director · 2026-09-01
Sold
$80
Bitterman Kevin
director · 2026-09-01
Sold
$5K
Bitterman Kevin
director · 2026-09-01
Sold
$6K
About Disc Medicine, Inc.
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting…
Biotechnology
Fair value and Payback Price are estimates from the company's reported financials, not investment advice. Prices as of the close of Oct 3, 2026. How the Payback Price works